Gyre Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GYRE and other ETFs, options, and stocks.

About GYRE

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). 

CEO
Han Ying
CEOHan Ying
Employees
5
Employees5
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1997
Founded1997
Employees
5
Employees5

GYRE Key Statistics

Market cap
850.85M
Market cap850.85M
Price-Earnings ratio
197.08
Price-Earnings ratio197.08
Dividend yield
Dividend yield
Average volume
523.12K
Average volume523.12K
High today
$10.45
High today$10.45
Low today
$9.26
Low today$9.26
Open price
$10.35
Open price$10.35
Volume
469.73K
Volume469.73K
52 Week high
$19.00
52 Week high$19.00
52 Week low
$6.11
52 Week low$6.11

People also own

Based on the portfolios of people who own GYRE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.